What is the recommended dilution and infusion protocol for ferric carboxymaltose (Ferinject) for 500 mg and 1000 mg doses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ferric Carboxymaltose Dilution and Infusion Protocol

Ferric carboxymaltose should be diluted in 100 mL of normal saline and infused over 20-30 minutes for both 500 mg and 1000 mg doses. 1

Standard Dilution Protocol

For Both 500 mg and 1000 mg Doses:

  • Diluent: 100 mL of 0.9% normal saline (NaCl)
  • Infusion time: 20-30 minutes
  • No test dose required (unlike some older iron formulations)

This recommendation comes from the 2024 expert consensus guidelines published in the American Journal of Hematology, which represents the most current and authoritative guidance on intravenous iron administration 1.

Administration Technique

Start the infusion slowly for the first several minutes to observe for any acute infusion reactions, then complete the remaining volume over the balance of the 20-30 minute period 1. This approach applies universally regardless of dose.

Key Points About U.S. Dosing:

  • In the United States, FCM is distributed as 750 mg vials
  • For a 500 mg dose: use 2/3 of one vial (with 250 mg wastage)
  • For a 1000 mg dose: use 1.33 vials (with 500 mg wastage, or administer two doses of 750 mg one week apart per FDA labeling)

Important Clinical Considerations

Hypophosphatemia Risk:

FCM should be avoided in patients requiring repeat infusions due to the association with treatment-emergent hypophosphatemia 1. This is a critical safety consideration that distinguishes FCM from other IV iron formulations like ferric derisomaltose.

Stability After Dilution:

Research demonstrates that FCM diluted in normal saline remains physically and chemically stable for up to 72 hours at 30°C when stored in polypropylene containers 2. However, the drug should be administered within 8 hours following dilution per standard practice recommendations 3.

Monitoring During Infusion:

Observe for minor infusion reactions (occurring in 1-3% of patients) including:

  • Flushing
  • Headache
  • Nausea
  • Hypotension
  • Back pain (more common in cirrhotic patients)

No premedication is routinely required, unlike with older high-molecular-weight iron dextran formulations.

Comparison to International Practice

While the U.S. protocol specifies 100 mL dilution over 20-30 minutes, it's worth noting that throughout Europe and Asia, FCM is routinely administered as a 1000 mg single infusion over 15-30 minutes with an excellent safety profile 1. Some studies have used 250 mL dilution volumes over 15-30 minutes 4, though the consensus guideline supports the 100 mL standard.

Post-Infusion Care

Do not check iron parameters within 4 weeks of infusion, as circulating iron interferes with assays and produces spurious results 1. Optimal timing for laboratory evaluation is 4-8 weeks post-infusion, including CBC, ferritin, and transferrin saturation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.